drugset / Trial / NCT00674050
A Study Designed to Determine if the Drugs Albuterol (Salbutamol) and Fluticasone Have an Effect on the Pharmacokinetics of the Investigational Product Technosphere® Insulin Inhalation Powder in Healthy Volunteers
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study will investigate the effects of inhaled albuterol \& fluticasone on one dose of TI Inhalation Powder. A total of 12 eligible subjects will be enrolled.
Timeline
- Start
- 2008-05
- Primary completion
- 2008-09
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone | Other / unclassified | 500 ug | Inhaled |
| Subject | Insulin | Protein / enzyme biologic | 3 iu | Inhaled |
| Subject | Insulin | Protein / enzyme biologic | 5 mg | Inhaled |
| Subject | Insulin | Protein / enzyme biologic | 10 mg | Inhaled |
| Subject | Insulin | Protein / enzyme biologic | 15 iu | Inhaled |
| Subject | Insulin | Protein / enzyme biologic | 30 iu | Inhaled |
| Subject | Salbutamol | Unknown | 200 ug | Inhaled |